The majority of untreated cases of<unk>  will progress to end-stage kidney disease. Important prognostic factors include the degree of proteinuria and initial response to therapy. Patients with nephrotic-range (>3.5 g/day) proteinuria have over a 50% rate of progression to end-stage kidney disease at 10 years. Only 15% of patients with sub-nephrotic ranges of proteinuria progress to end-stage renal failure at 10 years. Initial response to therapy also dictates long-term outcomes. Those defined as having a "complete response" typically manifest a proteinuria of <300 mg/day; those with a "partial response" manifest a sub-nephrotic range of proteinuria, <3.5 g/day. Either complete or partial response is associated with 80% kidney survival at 10-years, compared with about 50% among non-responsive patients.
Focal segmental glomerulosclerosis
Membranous glomerulonephritis
Minimal mesangial glomerulonephritis
Mesangial proliferative glomerulonephritis
Focal proliferative nephritis
IgA nephropathy
Mesoamerican nephropathy
Membranoproliferative glomerulonephritis